Inventor · disambiguated record
Sarah F. Blanchette
Also filed as: BLANCHETTE SARAH F
4 granted patents·5 pending applications·27 citations·filing 2016–2025
76Inventor score
Top patents by PatentIndex Score
9 records- 0195US11844795B2Combination therapy for cancer treatmentIPSEN BIOPHARM LTD·Filed 2022·Granted Dec 19, 2023·2 cites·15 claims
- 0293US10478428B2Combination therapy for cancer treatmentIPSEN BIOPHARM LTD·Filed 2017·Granted Nov 19, 2019·11 cites·17 claims
- 0392US9895365B2Combination therapy for cancer treatmentIPSEN BIOPHARM LTD·Filed 2016·Granted Feb 20, 2018·10 cites·20 claims
- 0490US11344552B2Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatinIPSEN BIOPHARM LTD·Filed 2017·Granted May 31, 2022·4 cites·15 claims
- 0583US2024358706A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2024·Application pending·0 cites
- 0677US2025381191A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2025·Application pending·0 cites
- 0775US2023062425A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinIPSEN BIOPHARM LTD·Filed 2022·Application pending·0 cites
- 0863US2020268742A1Combination Therapy for Cancer TreatmentIPSEN BIOPHARM LTD·Filed 2019·Application pending·0 cites
- 0954US2017049775A1Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and OxaliplatinMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →